Business description
Neogen Corporation (Nasdaq: NEOG) develops and markets products dedicated to food and animal safety. Neogen’s Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.
Management board & Supervisory board
| CEO |
| John Adent |
| Management board |
| David Naemura (ab 2.01.2023), Steven J. Quinlan (bis 1.01.2023), Amy M. Rocklin, Douglas E. Jones, Dr. Jason W. Lilly, Dr. Robert S. Donofrio, Jerome Hagedorn, Joseph A. Corbett, Julie L. Mann, Marylinn Munson, Shane M. Fitzwater |
| Supervisory board |
| James C. Borel, Aashima Gupta, Catherine E. Woteki, Darci L. Vetter, James P. Tobin, Jeffrey Capello, Ralph A. Rodriguez, Ronald Green, William T. Boehm |
Company data
| Name: |
Neogen Corp. |
| Address: |
620 Lesher Place,Lansing, Michigan 48912, USA |
| Phone: |
+1-517-372-9200 |
| Fax: |
+1-517-372-2006 |
| E-mail: |
corporate@neogen.com
|
| Internet: |
www.neogen.com |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
5/31 |
| Free Float: |
60.89% |
| IPO date: |
- |
Investor relations
| Name: |
Steven J. Quinlan |
| IR phone: |
+1-517-372-2280 |
| IR Fax: |
- |
| IR e-mail: |
ir@neogen.com
|